РОЛЬ N-КОНЦЕВОГО ФРАГМЕНТА МОЗГОВОГО НАТРИЙУРЕТИЧЕСКОГО ПЕПТИДА В ДИАГНОСТИКЕ НЕКОМПАКТНОГО МИОКАРДА У ДЕТЕЙ

некомпактный миокард, NT-proBNP, сердечная недостаточность, диагностика, дети

1. Sanchez-Quintana D., Garcia-Martinez V., Climent V., Hurle J. M. Morphological changes in the normal pattern of ventricular myoarchitecture in the developing human heart. Anat. Rec. 1995; 243: 483–495.

2. Sedmera D., Pexieder T., Vuillemin M. et al. Developmental patterning of the myocardium. Anat. Rec. 2000; 258: 319–337. 3. Srivastava D., Olson E. N. A genetic blueprint for cardiac development. Nature. 2000; 407: 221–226.

3. Nugent A. W., Daubeney P. E., Chondros P. et al. National Australian childhood cardiomyopathy study: the epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003; 348: 1639–1646.

4. Sasse-Klaassen S., Gerull B., Oechslin E. et al. Isolated noncompaction of the left ventricular myocardium in the adult is an autosomal dominant disorder in the majority of patients. Am J Med Genet. 2003; 119A: 162–167.

5. Junga G., Kneifel S., Von Smekal A. et al. Myocardial ischaemia in children with isolated ventricular non-compaction. Eur Heart J. 1999; 20 (12): 910–916.

6. Jenni R., Wyss C., Oechslin E., Kaufmann P. Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction. J Am Coll Cardiol. 2002; 39: 450–454.

7. Alsaileek A. A., Syed I., Seward J. B., Julsrud P. Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction. J Magn Reson Imaging. 2008; 27 (3): 621–624.

8. Finsterer J., Stollberger C., Feichtinger H. Histological appearance of left ventricular hypertrabeculation/noncompaction. Cardiology. 2002; 98: 162–164.

9. Freedom R., Yoo S-J., Perrin D. et al. The morphological spectrum of ventricular noncompaction. Cardiol Young. 2005; 15: 345–364.

10. Ross R. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992; 13: 72–75.

11. Toyono M., Kondo C., Nakajima Y. et al. Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction. Heart. 2001; 86: 4–6.

12. Braunwald E. The management of heart failure: the past, the present, and the future. Circ Heart Fail. 2008; 1: 58–62.

13. Katz A. M. Heart failure: pathophysiology, molecular biology, and clinical management. Philadelphia: Lippincott Williams & Wilkins. 2000.

14. Konstam M. A. «Systolic and diastolic dysfunction» in heart failure? Time for a new paradigm. J Card Fail. 2003; 9: 1–3.

15. Packer M. How should physician view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol. 1993; 71: 3–11.

16. Nakao K., Itoh H., Saito Y. et al. The natriuretic peptide family. Curr Opin Nephrol Hypertens. 1996; 5: 4–11.

17. Levin E. R., Gardner D. G., Samson W. K. Natriuretic peptides. N Engl J Med. 1998; 339: 321–328.

18. Johns M. C., Stephenson C. Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients. Am J Cardiol. 2008; 101: 76–81.

19. Davis G. K., Bamforth F., Sarpal A. B-type natriuretic peptide in pediatrics. Clin Biochem. 2006; 39: 600–605.

20. Mir T. S., Marohn S., Laer S. et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics. 2002; 110 (6): 76.

21. Bolger A. P., Sharma R., Li W. et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002; 106: 92–99.

22. Ohuchi H., Ohashi H., Park J. et al. Abnormal postexercise cardio: vascular recovery and its determinants in patients after right ventricular outflow tract reconstruction. Circulation. 2002; 106: 2819–2826.

23. Price J. F., Thomas A. K., Grenier M. et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006; 114: 1063–1069.

24. Архипова Е. Н., Родионова Т. В., Басаргина Е. Н., Маянский Н. А. Закономерности изменения содержания NT-proBNP в крови и их диагностическая значимость у детей с хронической сердечной недостаточностью. Лабораторная диагностика в педиатрии. 2012; 4 (3): 11–16.